Zevra Therapeutics, Inc.
ZVRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434647
In the last 90 days, Zevra Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 157 institutions reported holding it in 13F filings for Q2 2026, worth $642.0M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Zevra Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 111
- +3 vs. Q4 2024
- Shares held
- 35.5M
- +1.70M (+5.0%) vs. Q4 2024
- Total value
- $264.9M
- −$16.8M (−6.0%) vs. Q4 2024
- New holders
- 16
- 43 more added
- Sold out
- 13
- 29 more reduced
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZVRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 157 | $642.0M |
| Q1 2026 | 148 | $384.6M |
| Q4 2025 | 159 | $341.8M |
| Q3 2025 | 166 | $379.4M |
| Q2 2025 | 121 | $318.9M |
| Q1 2025 | 111 | $264.9M |
| Q4 2024 | 110 | $282.9M |
| Q3 2024 | 108 | $201.0M |
| Q2 2024 | 93 | $78.6M |
| Q1 2024 | 89 | $80.7M |
| Q4 2023 | 84 | $83.0M |
| Q3 2023 | 77 | $52.1M |
| Q2 2023 | 71 | $41.6M |
| Q1 2023 | 61 | $33.8M |
| Q4 2022 | 70 | $27.2M |
| Q3 2022 | 69 | $41.8M |
| Q2 2022 | 73 | $32.4M |
| Q1 2022 | 82 | $45.4M |
| Q4 2021 | 76 | $63.3M |
| Q3 2021 | 70 | $73.1M |
| Q2 2021 | 70 | $98.3M |
| Q1 2021 | 51 | $21.4M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Zevra Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| 683 Capital Management, LLC | 1,225,834 | $9.18M | 0.93% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,233,111 | $9.24M | 0.00% | +44,991+3.8% | Added |
| Altium Capital Management LP | 1,287,333 | $9.64M | 28.00% | −562,667−30.4% | Reduced |
| AIGH Capital Management LLC | 1,438,109 | $10.8M | 5.59% | +649,495+82.4% | Added |
| Nantahala Capital Management, LLC | 1,471,936 | $11.0M | 0.91% | −868,397−37.1% | Reduced |
| FMR LLC | 2,306,317 | $17.3M | 0.00% | −23,026−1.0% | Reduced |
| Vanguard Group Inc | 2,825,845 | $21.2M | 0.00% | +1,633+0.1% | Added |
| Adage Capital Partners GP, L.L.C. | 3,618,000 | $27.1M | 0.05% | −32,000−0.9% | Reduced |
| BlackRock, Inc. | 4,126,563 | $30.9M | 0.00% | +46,143+1.1% | Added |
| Woodline Partners LP | 4,615,625 | $34.6M | 0.22% | +476,032+11.5% | Added |
| Nuveen, LLC | 114,934 | – | – | +114,934 | New |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −292,772−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −85,818−100.0% | Sold out |
| Diadema Partners LP | 0 | $0 | 0.00% | −42,081−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −13,024−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −12,831−100.0% | Sold out |
| Profund Advisors LLC | 0 | $0 | 0.00% | −12,055−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −11,728−100.0% | Sold out |
| Venturi Wealth Management, LLC | 0 | $0 | 0.00% | −531−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −370−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −165−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −87−100.0% | Sold out |
| Hantz Financial Services, Inc. | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |